1 Amphetamine use (UA) |
7 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.1 Amphetamine dependence |
1 |
24 |
Mean Difference (IV, Random, 95% CI) |
1.5 [‐4.24, 7.24] |
1.2 Methamphetamine dependence |
6 |
449 |
Mean Difference (IV, Random, 95% CI) |
‐0.28 [‐0.87, 0.31] |
2 Amphetamine use (hair analysis) |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
2.1 Amphetamine dependence |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
2.2 Methamphetamine dependence |
1 |
22 |
Mean Difference (IV, Random, 95% CI) |
0.53 [‐6.02, 7.08] |
3 Sustained abstinence |
6 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
3.1 Amphetamine dependence |
1 |
24 |
Risk Ratio (M‐H, Random, 95% CI) |
0.89 [0.53, 1.49] |
3.2 Methamphetamine dependence |
5 |
535 |
Risk Ratio (M‐H, Random, 95% CI) |
1.24 [0.88, 1.74] |
4 Self‐reported amphetamine use |
3 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
4.1 Amphetamine dependence |
1 |
24 |
Mean Difference (IV, Random, 95% CI) |
0.5 [‐4.76, 5.76] |
4.2 Methamphetamine dependence |
2 |
109 |
Mean Difference (IV, Random, 95% CI) |
0.07 [‐11.39, 11.52] |
5 Retention in treatment |
11 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
5.1 Amphetamine dependence |
2 |
58 |
Risk Ratio (M‐H, Random, 95% CI) |
0.90 [0.42, 1.94] |
5.2 Methamphetamine dependence |
9 |
733 |
Risk Ratio (M‐H, Random, 95% CI) |
1.03 [0.91, 1.16] |
6 Amphetamine craving |
2 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
6.1 Amphetamine dependence |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
6.2 Methamphetamine dependence |
2 |
144 |
Std. Mean Difference (IV, Random, 95% CI) |
0.07 [‐0.44, 0.59] |
7 Dropouts due to any adverse event |
10 |
|
Risk Difference (M‐H, Random, 95% CI) |
Subtotals only |
7.1 Amphetamine dependence |
2 |
58 |
Risk Difference (M‐H, Random, 95% CI) |
0.02 [‐0.08, 0.11] |
7.2 Methamphetamine dependence |
8 |
582 |
Risk Difference (M‐H, Random, 95% CI) |
0.00 [‐0.03, 0.04] |
8 Dropouts due to cardiovascular adverse events |
8 |
|
Risk Difference (M‐H, Random, 95% CI) |
Subtotals only |
8.1 Amphetamine dependence |
2 |
58 |
Risk Difference (M‐H, Random, 95% CI) |
0.0 [‐0.09, 0.09] |
8.2 Methamphetamine dependence |
6 |
312 |
Risk Difference (M‐H, Random, 95% CI) |
0.01 [‐0.03, 0.04] |
9 Dropouts due to psychiatric adverse events |
7 |
|
Risk Difference (M‐H, Random, 95% CI) |
Subtotals only |
9.1 Amphetamine dependence |
7 |
290 |
Risk Difference (M‐H, Random, 95% CI) |
‐0.02 [‐0.06, 0.02] |
9.2 Methamphetamine dependence |
5 |
232 |
Risk Difference (M‐H, Random, 95% CI) |
‐0.03 [‐0.07, 0.02] |